Among the first pharmacies in the US to receive URAC Rare Disease Designation
URAC, an independent healthcare accreditation organization, announced that Fairview Pharmacy Services, part of Fairview Health Services, has received Rare Disease Pharmacy Designation. This designation signifies a commitment to high-quality pharmacy practice and advanced expertise with rare disease treatment. Fairview also holds URAC’s Specialty Pharmacy accreditation and Mail Service Pharmacy accreditation.
Shawn Griffin, MD, URAC president and CEO, gave kudos to Fairview.
“Pharmacies and related pharmaceutical services play a critical role in the healthcare delivery system, now more than ever. Given the complicated nature of chronic disease, pharmacies like Fairview do much more than simply fill a prescription,” he said. “As trusted experts at the frontline of care delivery, they often provide targeted patient support and education to ensure proper medication management. By achieving two URAC pharmacy accreditations and a rare disease designation, Fairview Pharmacy Services has demonstrated excellence in quality care delivery and their long-term commitment to ensuring patient safety and improving outcomes.”
Fairview Health Services is a Minneapolis-based nonprofit health system.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.